Ataxia - Telangiectasia
[for Professionals mainly]
Gene Map Locus: 11q22.3 … AT is an autosomal recessive disorder characterized by cerebellar ataxia, telangiectases, immune defects, and a predisposition to malignancy. Chromosomal breakage is a feature. AT cells are abnormally sensitive to killing by ionizing radiation (IR), and abnormally resistant to inhibition of DNA synthesis by ionizing radiation … 4 complementation groups for the classical form of the disease … Clinical Features … Homozygotes … Patients present in early childhood with progressive cerebellar ataxia and later develop conjunctival telangiectases, other progressive neurologic degeneration, sinopulmonary infection, and malignancies. Telangiectases typically develop between 3 and 5 years of age … Ataxia can be misdiagnosed as ataxic cerebral palsy before the appearance of oculocutaneous telangiectases … Gonadal dysfunction in ataxia - telangiectasis was discussed by Miller and Chatten (1967) … The oldest known AT patient … at age 52 years … AT may be the most common syndromic progressive cerebellar ataxia of early childhood. Truncal ataxia precedes appendicular ataxia ... Chromosomal breakage in AT … Leukemia and chromosomal abnormalities occur in at least 2 other mendelian disorders--Fanconi pancytopenia and Bloom syndrome … Lymphomas in AT patients tend to be of B-cell origin … leukemias tend to be of T-CLL type … Other solid tumors, including medulloblastomas and gliomas, occur with increased frequency in AT … Swift et al (1987) examined the cancer risk of heterozygotes for AT in 128 families, including 4 of Amish ancestry, 110 white non-Amish families, and 14 black families. They measured documented cancer incidence rather than cancer mortality … Incidence rates in AT relatives were significantly elevated over those in spouse controls … Breast cancer in women was the cancer most clearly associated with heterozygosity for AT … Estimated that 8 to 18% of patients with breast cancer in the U.S. white population would be heterozygous for AT … Pippard et al (1988) confirmed this observation … Excess of breast cancer deaths in British mothers of AT patients … Most frequent cancer site in the blood relatives was the female breast … Estimated risk of cancer of all types among heterozygotes as compared with noncarriers was 3.8 in men and 3.5 in women … Genes responsible for most cases of AT are located on 11q … Athma et al (1996) determined the AT gene carrier status blood relatives … 33 women with breast cancer who could be genotyped; 25 of these were AT heterozygotes, compared to an expected 14.9 … Athma et al (1996) estimated that, of all breast cancers in the U.S., 6.6% may occur in women who are AT heterozygotes.

NINDS Ataxia Telangiectasia Information Page
National Institute of Neurological Disorders and Stroke
"... very brief but it gives a basic understanding of A-T ..."

Ataxia-Telangiectasia Society
"... resource for families ..."

National Ataxia Foundation [USA]
[Support Group]
Established in 1957 … An estimated 150,000 people in the United States are affected.

Questions and Answers: Ataxia Telangiectasia
National Institutes of Health
Ataxia telangiectasia (A-T) is a rare, recessive genetic disorder of childhood that occurs in about 1/40,000 and 1/100,000 persons worldwide. The ailment is progressive.

A-T Children's Project
Created to provide physicians, research scientists, families and support providers with information … What is A-T?

Ataxia-telangiectasia
Medline Plus, July 1, 2007
[Spanish]
Nombres alternativos: Sindrome de Louis-Bar ... Definicion: Es una enfermedad poco comun de la infancia que afecta el cerebro y otras partes del cuerpo. Ataxia se refiere a movimientos descoordinados, como caminar, y telangiectasia es el agrandamiento de los vasos sanguineos (capilares) justo por debajo de la superficie de la piel. Las telangiectasias aparecen como pequenas venas rojas similares a una arana.

Ataxia - Telangiectasia
I.B.I.S. Birth Defects, May 8, 2003
[Ukrainian]
A fact sheet for parents in Ukrainian
What is ataxia - telangiectasia ... Symptoms and features of the disease ... Prevalence ... Prognosis ... Connection to other diseases ... Inheritance ... Diagnosis ...

________________________________________________________________________________________________

Last Updated: 2023/07/19

________________________________________________________________________________________________